Pfizer’s Varenicline Smoking Cessation NDA Includes Comparison To Zyban
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer’s prescription smoking cessation agent varenicline will have a user fee deadline in the first half of September 2006, assuming a standard 10-month review.